Related references
Note: Only part of the references are listed.Overall survival in patients with metastatic melanoma
Xue Song et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
Antoni Ribas et al.
LANCET ONCOLOGY (2015)
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
Alexander M. M. Eggermont et al.
LANCET ONCOLOGY (2015)
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy
Ninh M. La-Beck et al.
PHARMACOTHERAPY (2015)
The Rapid Emergence of Novel Therapeutics in Advanced Malignant Melanoma
Lijo John et al.
DERMATOLOGY AND THERAPY (2015)
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
Jedd D. Wolchok et al.
PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: PRIX GALIEN USA 2012 (2013)
Autoimmune Disease and Subsequent Urological Cancer
Xiangdong Liu et al.
JOURNAL OF UROLOGY (2013)
Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline
Claus Garbe et al.
EUROPEAN JOURNAL OF CANCER (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases
Glinda S. Cooper et al.
JOURNAL OF AUTOIMMUNITY (2009)
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, Interleukin-2, and Interferon Alfa-2b With Cisplatin, Vinblastine, and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group
Michael B. Atkins et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Epidemiology of autoimmune diseases in Denmark
William W. Eaton et al.
JOURNAL OF AUTOIMMUNITY (2007)
Cytokine-based therapy and biochemotherapy for advanced melanoma
MB Atkins
CLINICAL CANCER RESEARCH (2006)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)